Zurich Cantonal Bank
IMRX icon

Zurich Cantonal Bank’s Immuneering IMRX Stock Holding History

Zurich Cantonal Bank’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$51 – 2796
2023
Q2 		$51 Hold
5
– – ﹤0.01% 2788
2023
Q1 		$49 Sell
5
-4,143
-100% -$23.5K ﹤0.01% 2846
2022
Q4 		$20.1K Buy
+4,148
New +$36.7K ﹤0.01% 2755

Other funds holding IMRX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Zurich Cantonal Bank's IMRX Position: Q3 2023 in Review

Zurich Cantonal Bank sold out of Immuneering (IMRX) in Q3 2023, closing a stake of 5 shares — an estimated $51 sold.

Zurich Cantonal Bank first reported a position in IMRX in Q4 2022 and held it in 3 quarters. The position peaked at $20.1K in Q4 2022. 52 funds tracked by Wall St. Rank hold IMRX as of Q3 2023.

  • Zurich Cantonal Bank reported no remaining Immuneering position as of Q3 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 5 Immuneering shares in Q3 2023, an estimated $51.
  • Zurich Cantonal Bank first reported a position in Immuneering in Q4 2022 and held it in 3 quarters.
  • Zurich Cantonal Bank's Immuneering position peaked at $20.1K in Q4 2022.
  • 52 funds tracked by Wall St. Rank held Immuneering as of Q3 2023.

Based on Zurich Cantonal Bank's 13F filing for Q3 2023, filed 25 Oct 2023.